ES2291933T3 - Tienopirroles como agentes antivirales. - Google Patents

Tienopirroles como agentes antivirales. Download PDF

Info

Publication number
ES2291933T3
ES2291933T3 ES04768385T ES04768385T ES2291933T3 ES 2291933 T3 ES2291933 T3 ES 2291933T3 ES 04768385 T ES04768385 T ES 04768385T ES 04768385 T ES04768385 T ES 04768385T ES 2291933 T3 ES2291933 T3 ES 2291933T3
Authority
ES
Spain
Prior art keywords
thieno
cyclohexyl
acid
methyl
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES04768385T
Other languages
English (en)
Spanish (es)
Inventor
Barbara Attenni
Jose Ignacio Martin Hernando
Savina Malancona
Frank Narjes
Jesus Maria Ontoria Ontoria
Michael Rowley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Istituto di Ricerche di Biologia Molecolare P Angeletti SpA
Original Assignee
Istituto di Ricerche di Biologia Molecolare P Angeletti SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Istituto di Ricerche di Biologia Molecolare P Angeletti SpA filed Critical Istituto di Ricerche di Biologia Molecolare P Angeletti SpA
Application granted granted Critical
Publication of ES2291933T3 publication Critical patent/ES2291933T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ES04768385T 2003-09-09 2004-09-07 Tienopirroles como agentes antivirales. Expired - Lifetime ES2291933T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0321003.6A GB0321003D0 (en) 2003-09-09 2003-09-09 Compounds, compositions and uses
GB0321003 2003-09-09

Publications (1)

Publication Number Publication Date
ES2291933T3 true ES2291933T3 (es) 2008-03-01

Family

ID=29226699

Family Applications (1)

Application Number Title Priority Date Filing Date
ES04768385T Expired - Lifetime ES2291933T3 (es) 2003-09-09 2004-09-07 Tienopirroles como agentes antivirales.

Country Status (11)

Country Link
US (1) US7781431B2 (https=)
EP (1) EP1664059B1 (https=)
JP (1) JP2007505091A (https=)
CN (1) CN1849323A (https=)
AT (1) ATE373005T1 (https=)
AU (1) AU2004270470A1 (https=)
CA (1) CA2537545A1 (https=)
DE (1) DE602004008945T2 (https=)
ES (1) ES2291933T3 (https=)
GB (1) GB0321003D0 (https=)
WO (1) WO2005023819A1 (https=)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2534649A1 (en) 2003-08-01 2005-02-10 Genelabs Technologies, Inc. Bicyclic imidazol derivatives against flaviviridae
WO2005049622A1 (ja) * 2003-11-19 2005-06-02 Japan Tobacco Inc. ５－５員縮合複素環化合物及びそのｈｃｖポリメラーゼ阻害剤としての用途
US20070049593A1 (en) 2004-02-24 2007-03-01 Japan Tobacco Inc. Tetracyclic fused heterocyclic compound and use thereof as HCV polymerase inhibitor
GB0416396D0 (en) * 2004-07-22 2004-08-25 Angeletti P Ist Richerche Bio Therapeutic agents
US7659263B2 (en) 2004-11-12 2010-02-09 Japan Tobacco Inc. Thienopyrrole compound and use thereof as HCV polymerase inhibitor
CA2606195C (en) 2005-05-02 2015-03-31 Merck And Co., Inc. Hcv ns3 protease inhibitors
GB0509326D0 (en) * 2005-05-09 2005-06-15 Angeletti P Ist Richerche Bio Therapeutic compounds
NZ565269A (en) 2005-08-01 2010-03-26 Merck & Co Inc Macrocyclic peptides as HCV NS3 protease inhibitors
GB0609492D0 (en) 2006-05-15 2006-06-21 Angeletti P Ist Richerche Bio Therapeutic agents
GB0612423D0 (en) 2006-06-23 2006-08-02 Angeletti P Ist Richerche Bio Therapeutic agents
AU2007309546A1 (en) 2006-10-24 2008-05-02 Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. HCV NS3 protease inhibitors
CA2667146C (en) 2006-10-24 2016-01-19 Merck & Co., Inc. Hcv ns3 protease inhibitors
AU2007309488B2 (en) 2006-10-24 2012-10-11 Merck Sharp & Dohme Corp. HCV NS3 protease inhibitors
US8377874B2 (en) 2006-10-27 2013-02-19 Merck Sharp & Dohme Corp. HCV NS3 protease inhibitors
BRPI0718161A2 (pt) 2006-10-27 2013-11-26 Merck & Co Inc Composto, composição farmacêutica, e, uso do composto.
GB0625349D0 (en) 2006-12-20 2007-01-31 Angeletti P Ist Richerche Bio Therapeutic compounds
CA2672250C (en) 2006-12-20 2013-04-30 Ian Stansfield Antiviral indoles
GB0625345D0 (en) 2006-12-20 2007-01-31 Angeletti P Ist Richerche Bio Therapeutic compounds
JP2010533699A (ja) 2007-07-17 2010-10-28 イステイチユート・デイ・リチエルケ・デイ・ビオロジア・モレコラーレ・ピ・アンジエレツテイ・エツセ・ピー・アー Ｃ型肝炎感染症の治療のための大環状インドール誘導体
AU2008277377B2 (en) 2007-07-19 2013-08-01 Msd Italia S.R.L. Macrocyclic compounds as antiviral agents
EP2234977A4 (en) 2007-12-19 2011-04-13 Boehringer Ingelheim Int VIRAL POLYMERASE INHIBITORS
WO2009134624A1 (en) 2008-04-28 2009-11-05 Merck & Co., Inc. Hcv ns3 protease inhibitors
US8126839B2 (en) * 2008-06-19 2012-02-28 Yahoo! Inc. Methods and apparatuses for adapting a ranking function of a search engine for use with a specific domain
EA019327B1 (ru) 2008-07-22 2014-02-28 Мерк Шарп Энд Домэ Корп. Макроциклическое хиноксалиновое соединение в качестве ингибитора протеазы вгс ns3
CN102271699A (zh) 2009-01-07 2011-12-07 西尼克斯公司 用于治疗hcv和hiv感染的环孢菌素衍生物
US8828930B2 (en) 2009-07-30 2014-09-09 Merck Sharp & Dohme Corp. Hepatitis C virus NS3 protease inhibitors
US20110152243A1 (en) * 2009-12-23 2011-06-23 Abbott Laboratories Novel thienopyrrole compounds
CN105399697A (zh) * 2014-09-12 2016-03-16 苏州旺山旺水生物医药有限公司 一种氨基磺酰基类化合物、其制备方法及用途
EP3246330A1 (en) * 2016-05-18 2017-11-22 Istituto Europeo di Oncologia S.r.l. Imidazoles as histone demethylase inhibitors
SG11202012616RA (en) * 2018-08-21 2021-02-25 Kyorin Pharmaceutical Co Ltd Bicyclic heteroaromatic ring derivative

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3706810A (en) * 1970-09-15 1972-12-19 American Cyanamid Co N-morpholinoalkyl-thieno(3,2-b)pyrrole-5-carboxamides
SU367098A1 (ru) * 1971-01-20 1973-01-23 Способ получения производных 4,5-диоксотиено- -
SU478833A1 (ru) * 1972-12-29 1975-07-30 Всесоюзный Научно-Исследовательский Химико-Фармацевтический Институт Им.С.Орджоникидзе Способ получени производных тиено -(3,2-в)-пиррола
JPH04356029A (ja) 1990-07-02 1992-12-09 Japan Synthetic Rubber Co Ltd 非線形光学素子
JPH04179949A (ja) * 1990-11-15 1992-06-26 Fuji Photo Film Co Ltd 新規な色素形成カプラーおよび該カプラーを用いたハロゲン化銀カラー写真感光材料
US5340833A (en) * 1992-05-01 1994-08-23 Eisai Co., Ltd. Urokinase inhibitors
EP1162196A4 (en) 1999-12-27 2003-04-16 Japan Tobacco Inc COMPOUNDS WITH JOINED CYCLES AND THEIR USE AS MEDICAMENTS
US6448281B1 (en) 2000-07-06 2002-09-10 Boehringer Ingelheim (Canada) Ltd. Viral polymerase inhibitors
JP2003212846A (ja) * 2001-06-26 2003-07-30 Japan Tobacco Inc 縮合環化合物及びｃ型肝炎治療剤
AR035543A1 (es) 2001-06-26 2004-06-16 Japan Tobacco Inc Agente terapeutico para la hepatitis c que comprende un compuesto de anillo condensado, compuesto de anillo condensado, composicion farmaceutica que lo comprende, compuestos de benzimidazol, tiazol y bifenilo utiles como intermediarios para producir dichos compuestos, uso del compuesto de anillo con
CA2448737C (en) 2001-07-20 2010-06-01 Boehringer Ingelheim (Canada) Ltd. Viral polymerase inhibitors
EP2335700A1 (en) 2001-07-25 2011-06-22 Boehringer Ingelheim (Canada) Ltd. Hepatitis C virus polymerase inhibitors with a heterobicylic structure
WO2003026587A2 (en) 2001-09-26 2003-04-03 Bristol-Myers Squibb Company Compounds useful for treating hepatitus c virus
GB0222909D0 (en) * 2002-10-03 2002-11-13 Astrazeneca Ab Novel process and intermediates
BRPI0409465A (pt) * 2003-04-17 2006-05-02 Pfizer Prod Inc derivados de carboxamida como agentes antidiabéticos

Also Published As

Publication number Publication date
GB0321003D0 (en) 2003-10-08
DE602004008945D1 (en) 2007-10-25
JP2007505091A (ja) 2007-03-08
AU2004270470A1 (en) 2005-03-17
ATE373005T1 (de) 2007-09-15
CA2537545A1 (en) 2005-03-17
EP1664059B1 (en) 2007-09-12
CN1849323A (zh) 2006-10-18
US7781431B2 (en) 2010-08-24
EP1664059A1 (en) 2006-06-07
WO2005023819A1 (en) 2005-03-17
WO2005023819A9 (en) 2006-03-23
DE602004008945T2 (de) 2008-05-29
US20090036443A1 (en) 2009-02-05

Similar Documents

Publication Publication Date Title
ES2291933T3 (es) Tienopirroles como agentes antivirales.
AU2018361364B2 (en) Novel, highly active amino-thiazole substituted indole-2-carboxamides active against the hepatitis B virus (HBV)
US7485633B2 (en) Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
AU638400B2 (en) Azabicyclic heterocyclic compounds
US7973026B2 (en) Thienopyrroles as antiviral agents
US20070167447A1 (en) Indole acetamides as inhibitors of the hepatitis c virus ns5b polymerase
JP2007517843A (ja) Ｃｈｋ１阻害剤であるチオフェン誘導体
JP2008517986A (ja) 抗ウイルス薬としての四環式インドール誘導体
JP2022506337A (ja) Ｂ型肝炎ウイルス（ｈｂｖ）に対して活性を有する６，７－ジヒドロ－４ｈ－ピラゾロ［１，５－ａ］ピラジンインドール－２－カルボキサミド
BRPI0714346A2 (pt) agentes antivirais
ES2985494T3 (es) Compuesto heterocíclico
ES2394550T3 (es) Clorotiofen-amidas como inhibidores de los factores Xa de coagulación y trombina
DE102005028077A1 (de) Alkinyl-substituierte Thiophene
ES2314443T3 (es) Tiofenos sustituidos y sus usos.
AU2019373677B2 (en) Novel urea 6,7-dihydro-4H-pyrazolo(4,3-c)pyridines active against the hepatitis B virus (HBV)
WO2018109641A1 (en) 3-carboxylic acid pyrroles as nrf2 regulators
TW201116531A (en) Ring-annulated dihydropyrrolo[2,1-a]isoquinolines
CN106470974B (zh) 用于治疗病毒感染的化合物
US20090197856A1 (en) Antiviral compounds
CN106715445A (zh) 作为ftl3和jak抑制剂的大环n‑芳基‑三环嘧啶‑2‑胺聚醚的衍生物
HK1234405A1 (en) Compounds for treating viral infections